Site Search
Professionals 256 results
Capabilities 56 results
Practice Area
We routinely help clients protect and commercialize their intellectual property (IP) assets and provide due diligence on complex technology and IP transactions. We negotiate and draft IP licenses and transfers; provide strategic guidance on optimal structures for IP and IT transactions; and evaluate copyright, trademark, and patent portfolios and provide related due diligence activities in connection with IPOs, mergers and acquisitions, private equity investments, licenses, and other corporate transactions.
Practice Area
Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
Practice Area
The United States International Trade Commission (ITC) is an increasingly popular venue for patent infringement litigation. More and more companies are seeking to halt importations of infringing products into the United States by turning to the ITC for expedited relief. Section 337 investigations conducted by the ITC provide complainants with a “fast track” to remedy IP matters that typically go to trial within 10 months. Since many Section 337 cases go to trial, selecting an ITC litigation team with a command of the technology, patent law, and specialized procedural practice is extremely important. We have handled more than 100 cases before the ITC.
Experience 26 results
Experience
|June 25, 2025
Winston Secures Federal Circuit Affirmance of 101 Victory for Polycom
Experience
|April 30, 2025
Insights & News 1,533 results
Recognitions
|August 21, 2025
|1 Min Read
Winston Attorneys Recognized in The Best Lawyers in America® 2026
The 32nd edition of The Best Lawyers in America® 2026 includes 143 Winston & Strawn attorneys. The outlet identifies award winners by conducting and compiling exhaustive peer-review surveys. During this process, tens of thousands of leading lawyers confidentially assess their professional peers.
Investigations, Enforcement, & Compliance Alerts
|August 18, 2025
|2 Min Read
PE Fund on Hook for Portco’s False Claims Act Cybersecurity Violations
DOJ False Claims Act (FCA) settlements related to cybersecurity typically have focused on false representations by a government contractor of its compliance with cybersecurity requirements. A recently announced settlement shows that private equity owners are not immune from potential FCA liability.
In the Media
|August 7, 2025
|1 Min Read
Yulia Makarova and Kimberly Prior Discuss Guiding Clients Through the GENIUS Act with IFLR
Winston & Strawn Winston & Strawn Digital Assets Group co-chair Kimberly Prior and partner Yulia Makarova were featured in an IFLR article sharing their insights on client reaction, increased demand for their legal knowledge, and compliance challenges for non-US issuers following the passing of the GENIUS Act. The act, passed by the House of Representatives on July 17 and signed by the President on July 18, brings clarity to the digital assets markets after years of regulatory uncertainty legitimizing the use of payment stablecoins in the US financial system and providing detailed requirements for compliance and governance.
Other Results 47 results
Law Glossary
An original work of authorship that is fixed in a tangible form and exhibits at least a minimal amount of creativity may be protected by U.S. copyright law. Under the law, a copyright owner has various exclusive rights to use the protected work, including the right to make copies of it; create derivative works based on it; and distribute it to the public. For certain types of works, the copyright owner also has the exclusive right to publicly perform or publicly display the work.
Law Glossary
What Is the Standard for the FDA to Grant a Biosimilar License?
Granting a Biosimilar License
Law Glossary
Colloquially referred to as the “patent dance,” the BPCIA provides a framework that includes certain steps and a schedule during which the applicant and reference product sponsor exchange confidential information disclosed in the aBLA. During the patent dance, the applicant and sponsor identify the patents that could be litigated in the future during two potential phases of litigation. In the first phase, the sponsor can allege infringement of a subset of the patents identified during the patent dance. The second phase begins after the sponsor receives the Notice of Commercial Marketing from the applicant. During this second phase, the sponsor can assert any remaining patents that were not asserted in the first phase.